MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-04-2025
Country |
 USA |
IPO year |
1995 |
Industry |
Diagnostics research |
Stock Exchange |
NYSESPB |
Shares |
59.4 M |
Market Cap[1] |
$ 19.8 B |
EBITDA (LTM) |
$ 852 M |
P/E (LTM) |
33.79 |
P/S (LTM) |
6.57 |
EPS (LTM) |
9.73 |
Other stocks of industry "Diagnostics research"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
- | -6.23 % | $ 30.6 M | Nasdaq Global Market |  Germany |
 |
Trinity Biotech plc
TRIB
|
$ 0.73 | -1.86 % | $ 61.9 M | Nasdaq Global Select Market |  Irlanda |
|
Akumin
AKU
|
- | -17.87 % | $ 25.9 M | Nasdaq Capital Market |  Canada |
 |
Aspira Women's Health
AWH
|
- | -6.19 % | $ 10.5 M | Nasdaq Capital Market,SPB | USA |
 |
Burning Rock Biotech Limited
BNR
|
$ 29.0 | -3.07 % | $ 316 M | Nasdaq Global Market |  China |
 |
Brainsway Ltd.
BWAY
|
$ 23.87 | -0.13 % | $ 99.4 M | Nasdaq Global Select Market |  Israel |
 |
Accelerate Diagnostics
AXDX
|
- | -61.36 % | $ 2.46 M | Nasdaq Global Select Market | USA |
 |
Biocept
BIOC
|
- | -13.05 % | $ 7.29 M | Nasdaq Capital Market | USA |
 |
BioNano Genomics
BNGO
|
$ 1.14 | -2.16 % | $ 1.45 M | Nasdaq Capital Market,SPB | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
- | - | $ 562 M | Nasdaq Global Select Market |  Britain |
 |
Chembio Diagnostics
CEMI
|
- | 0.22 % | $ 16.8 M | Nasdaq Capital Market | USA |
 |
Check-Cap Ltd.
CHEK
|
- | - | $ 9.42 M | Nasdaq Capital Market | Israel |
 |
Celcuity
CELC
|
$ 104.95 | -1.72 % | $ 4.14 B | Nasdaq Global Select Market | USA |
 |
Co-Diagnostics
CODX
|
- | - | $ 79.8 M | Nasdaq Capital Market | USA |
 |
Danaher Corporation
DHR
|
$ 210.56 | -0.33 % | $ 154 B | NYSE,SPB | USA |
 |
Castle Biosciences
CSTL
|
$ 29.41 | -6.17 % | $ 817 M | Nasdaq Global Market,SPB | USA |
 |
Global Cord Blood Corporation
CO
|
- | - | $ 399 M | NYSE | China |
 |
Fluidigm Corporation
FLDM
|
- | 1.08 % | $ 308 M | Nasdaq Global Select Market | USA |
 |
Quest Diagnostics Incorporated
DGX
|
$ 202.21 | -0.11 % | $ 22.4 B | NYSE,SPB | USA |
 |
Genetic Technologies Limited
GENE
|
- | - | $ 7.1 B | Nasdaq Capital Market |  Australia |
 |
Genetron Holdings Limited
GTH
|
- | 0.12 % | $ 80.1 M | Nasdaq Global Market | China |
 |
PRA Health Sciences, Inc.
PRAH
|
- | - | $ 10.7 B | Nasdaq Global Select Market | USA |
 |
DexCom
DXCM
|
$ 73.08 | 1.11 % | $ 28.5 B | Nasdaq Global Select Market,SPB | USA |
 |
DarioHealth Corp.
DRIO
|
$ 11.75 | 2.8 % | $ 333 M | Nasdaq Capital Market | Israel |
 |
CareDx, Inc
CDNA
|
$ 18.83 | -5.23 % | $ 1.01 B | Nasdaq Global Market,SPB | USA |
 |
DermTech
DMTK
|
- | -11.32 % | $ 2.94 M | Nasdaq Capital Market,SPB | USA |
 |
Enzo Biochem
ENZ
|
- | -8.98 % | $ 14.8 K | NYSE | USA |
 |
Illumina
ILMN
|
$ 117.53 | -2.06 % | $ 18.7 B | Nasdaq Global Select Market,SPB | USA |
 |
Fulgent Genetics
FLGT
|
$ 23.18 | -0.39 % | $ 701 M | Nasdaq Global Market | USA |
 |
Exact Sciences Corporation
EXAS
|
$ 103.45 | 0.15 % | $ 19.5 B | Nasdaq Capital Market,SPB | USA |
 |
Lantheus Holdings
LNTH
|
$ 74.31 | 1.54 % | $ 5.14 B | Nasdaq Global Select Market,SPB | USA |
 |
Guardant Health
GH
|
$ 103.36 | -2.84 % | $ 13 B | Nasdaq Global Select Market,SPB | USA |
 |
Heska Corporation
HSKA
|
- | - | $ 1.31 B | Nasdaq Capital Market,SPB | USA |
 |
HTG Molecular Diagnostics
HTGM
|
- | -20.0 % | $ 1.06 M | Nasdaq Capital Market | USA |
 |
ICON Public Limited Company
ICLR
|
$ 99.61 | 1.22 % | $ 8.22 B | Nasdaq Global Select Market,SPB | Irlanda |
 |
Interpace Biosciences
IDXG
|
$ 1.85 | 2.78 % | $ 8.12 M | Nasdaq Global Select Market | USA |
 |
QIAGEN N.V.
QGEN
|
- | - | $ 10.6 B | NYSE |  Niderland |
 |
Charles River Laboratories International
CRL
|
$ 169.68 | 3.11 % | $ 8.41 B | NYSE,SPB | USA |
 |
IDEXX Laboratories
IDXX
|
$ 635.6 | 0.77 % | $ 52.4 B | Nasdaq Global Select Market,SPB | USA |
 |
IQVIA Holdings
IQV
|
$ 166.19 | -1.87 % | $ 28.6 B | NYSE,SPB | USA |
 |
Koninklijke Philips N.V.
PHG
|
$ 31.19 | 0.73 % | $ 20 B | NYSE | Niderland |
|
Biodesix
BDSX
|
$ 13.26 | 4.0 % | $ 1.72 B | Nasdaq Global Market | USA |
 |
Quidel Corporation
QDEL
|
$ 22.47 | -4.85 % | $ 947 M | Nasdaq Global Select Market,SPB | USA |
 |
Laboratory Corporation of America Holdings
LH
|
$ 283.38 | 0.32 % | $ 23.8 B | NYSE,SPB | USA |
 |
Biomerica
BMRA
|
$ 2.17 | -2.25 % | $ 4.98 M | Nasdaq Capital Market | USA |
 |
Bioventus
BVS
|
$ 8.57 | -0.06 % | $ 537 M | Nasdaq Global Select Market | USA |
 |
Medpace Holdings
MEDP
|
$ 452.99 | 1.47 % | $ 13.1 B | Nasdaq Global Select Market,SPB | USA |
 |
Motus GI Holdings
MOTS
|
- | -34.28 % | $ 263 K | Nasdaq Global Select Market | Israel |
 |
National Research Corporation
NRC
|
$ 13.65 | 9.64 % | $ 335 M | Nasdaq Global Select Market | USA |
 |
Mettler-Toledo International
MTD
|
$ 1 378.44 | 0.14 % | $ 28.4 B | NYSE,SPB |  Schweiz |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.